HEATHER FINLAYSON: Open Payments
NPI 1952480873 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$72,106 in 226 payments from 19 companies in 2025. Trend: 2023 $28,713 · 2024 $41,106 · 2025 $72,106
Speaker / faculty: $45,470Travel & lodging: $13,017Consulting: $6,810Food & beverage: $6,720Education: $89
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 40 | $20,062 |
| UCB, Inc. | 38 | $14,595 |
| GENZYME CORPORATION | 31 | $12,744 |
| AstraZeneca Pharmaceuticals LP | 40 | $11,464 |
| GlaxoSmithKline, LLC. | 15 | $7,010 |
| E.R. Squibb & Sons, L.L.C. | 7 | $1,387 |
| Eli Lilly and Company | 1 | $1,200 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $1,153 |
| Amgen Inc. | 17 | $731 |
| Alexion Pharmaceuticals, Inc. | 3 | $549 |
Products named: TREMFYA, Bimzelx, KEVZARA, SAPHNELO, BENLYSTA, TALTZ, STRENSIQ, KRYSTEXXA.
Industry payments across CO — which companies pay providers there.
